Brett Froeliger

Professor

Psychiatry, Psychological Sciences,

froeligerb@health.missouri.edu

Dr. Brett Froelinger uses fMRI to evaluate the potential benefit of novel pharmacotherapies, behavioral interventions and non-invasive neural stimulation for treating substance-use disorder pathophysiology. He also leads the MU Cognitive Neuroscience Systems Core Facility.